Provincial Vaccine Coverage

About this resource

Vaccination can be an important part of staying healthy for people living with inflammatory arthritis, especially those taking medications that affect the immune system. Visit our About Vaccines page for an overview of vaccines that may be important for people living with autoimmune arthritis, including COVID-19, influenza, shingles, RSV, pneumococcal disease and HPV.

This resource provides information about:

National recommendations for COVID-19, influenza, shingles, RSV, pneumococcal and HPV vaccines
Publicly funded vaccine programs in each province and territory
Eligibility for people who are immunocompromised
Where vaccines may be available

What to know about public coverage

A vaccine may be nationally recommended without being publicly funded or paid for through the provincial or territorial health program. Coverage can depend on your age, health conditions, medications and where you live.

Having inflammatory arthritis, like rheumatoid arthritis, psoriatic arthritis, or axial spondylitis, does not automatically make someone eligible for publicly funded vaccination. Eligibility may depend on the medication being taken, including certain biologics, disease-modifying antirheumatic drugs (DMARDs) or corticosteroids like prednisone.

Speak with a healthcare provider or local public health authority to confirm which vaccines are recommended and publicly funded for you.

Please note

This resource is provided for general information only. CAPA makes every effort to keep the information accurate and current but is not responsible for errors or omissions. This resource was last updated in September 2026 and reflects the information available at the time of publication.

Vaccine recommendations and publicly funded programs may change. Consult your provincial or territorial health authority or a healthcare provider to confirm current eligibility and program details.

Find your province or territory:

PEI

NWT

British Columbia

National Recommendation (National Advisory Committee on Immunization)	Most people for whom COVID-19 vaccination is recommended receive one dose per year. People who are moderately to severely immunocompromised are recommended to receive two COVID-19 vaccine doses each year, generally one in the fall and another in the spring. For people starting or restarting a COVID-19 vaccine series, a third dose may be offered in some circumstances.
Public Funding	✅ Publicly funded for all BC residents aged 6 months and older. Eligible immunocompromised adults may receive an additional publicly funded spring dose.
Where can I get vaccinated?	Participating pharmacies Primary care provider Public health clinics
Learn More	National Guidance Canadian Immunization Guide – COVID-19 Vaccine British Columbia BC Centre for Disease Control – Adult Vaccine Recommendation HealthLink BC – Adult Immunizations

National Recommendation (National Advisory Committee on Immunization)	Influenza vaccination is recommended every year for everyone aged 6 months and older. People who are immunocompromised are a priority group and should receive a non-live influenza vaccine every year. The live attenuated influenza vaccine (FluMist®) is not recommended for people who are immunocompromised. High-dose flu vaccine or adjuvanted flu vaccines are recommended over standard-dose vaccines for adults aged 65 years and older.
Public Funding	✅ Publicly funded for all BC residents aged 6 months and older. Standard-dose influenza vaccine is publicly funded for everyone aged 6 months and older. Enhanced influenza vaccines are publicly funded for eligible adults aged 65 years and older. Adults who are immunocompromised and under age 65 generally receive the standard-dose vaccine.
Where can I get vaccinated?	Participating pharmacies (no prescription required) Primary care provider Public health offices and clinics
Learn More:	National Guidance Canadian Immunization Guide – Flu Vaccine British Columbia BC Centre for Disease Control – Adult Vaccine Recommendations HealthLink BC – Adult Immunizations

National Recommendation (National Advisory Committee on Immunization)	Shingles vaccine is strongly recommended for all adults aged 18 years and older who are immunocompromised. It is also recommended for adults aged 50 years and older. The vaccine is given as a two-dose series, with the second dose typically administered 2 to 6 months after the first. For people who are immunocompromised, the interval may be shortened to as little as 4 weeks if needed.
Public Funding	❌ Not publicly funded through British Columbia’s routine immunization program. Most adults must pay for the vaccine themselves. The estimated cost is approximately $400–600 for the two-dose series. Eligible First Nations and Inuit adults aged 60 years and older may receive coverage through the Non-Insured Health Benefits (NIHB) program.
Where can I get vaccinated?	Community pharmacies (private purchase) Primary care provider
Learn More:	National Guidance Canadian Immunization Guide – Shingles British Columbia BC Centre for Disease Control – Adult Vaccine Recommendations HealthLink BC – Adult Immunizations

National Recommendation (National Advisory Committee on Immunization)	RSV vaccination is recommended for adults aged 75 years and older. Adults aged 60 to 74 years who are at increased risk of severe RSV disease may also benefit from vaccination. Adults aged 75 years and older who have received a hematopoietic stem cell transplant should receive RSV vaccination.
Public Funding	❌ British Columbia does not currently have a publicly funded RSV vaccination program for adults. Most adults who wish to receive the vaccine must pay for it themselves. The estimated cost is approximately $200–300 per dose.
Where can I get vaccinated?	Community pharmacies (private purchase) Primary care provider
Learn More:	National Guidance Canadian Immunization Guide – RSV Vaccines British Columbia BC Centre for Disease Control – Adult Vaccine Recommendations HealthLink BC – Adult Immunizations

National Recommendation (National Advisory Committee on Immunization)	Pneu-C-20 or Pneu-C-21 is recommended for adults aged 65 years and older. Pneu-C-20 or Pneu-C-21 is also recommended for adults of any age who are immunocompromised or receiving immunosuppressive therapy. Most adults require one dose. If you have previously received an older pneumococcal vaccine (such as Pneu-P-23), you may still be eligible for Pneu-C-20. Speak with your healthcare provider about the schedule that is right for you.
Public Funding	✅ Publicly funded for adults aged 65 years and older who have not previously received eligible pneumococcal vaccines. ✅Publicly funded for adults of any age who are considered high risk, including people receiving immunosuppressive therapy. People taking eligible immunosuppressive therapies may qualify under the high-risk criteria; confirm eligibility with a healthcare provider or public health.
Where can I get vaccinated?	Community pharmacies (private purchase) Primary care provider
Learn More:	National Guidance Canadian Immunization Guide – Pneumococcal vaccines British Columbia BC Centre for Disease Control – Adult Vaccine Recommendations HealthLink BC – Adult Immunizations

National Recommendation (National Advisory Committee on Immunization)	HPV vaccination is recommended for everyone aged 9–26. Adults aged 27 and older may receive HPV vaccination following discussion and shared decision-making with a healthcare provider. If HPV vaccination is recommended for someone who is immunocompromised or living with HIV, a three-dose schedule is recommended, regardless of age. The usual schedule is: Dose 1: Day 0 Dose 2: 2 months after the first dose Dose 3: 6 months after the first dose
Public Funding	✅Publicly funded for adults under 27 years of age. ⚠ Some adults aged 27–45 may qualify for publicly funded vaccination, including people living with HIV and people belonging to specified sexual-orientation and gender-diverse communities. ❌Having inflammatory arthritis or taking immunosuppressive medication does not, by itself, qualify an adult aged 27–45 for publicly funded HPV vaccination in B.C. ❌Adults over 45 years of age are generally not eligible for public funding and would need to pay privately.
Where can I get vaccinated?	Community pharmacies (private purchase) Primary care provider
Learn More:	National Guidance Canadian Immunization Guide – HPV Vaccine British Columbia BC Centre for Disease Control – Adult Vaccine Recommendations HealthLink BC – Adult Immunizations

Alberta

National Recommendation (National Advisory Committee on Immunization)	Most people for whom COVID-19 vaccination is recommended receive one dose per year. People who are moderately to severely immunocompromised are recommended to receive two COVID-19 vaccine doses each year, generally one in the fall and another in the spring. For people starting or restarting a COVID-19 vaccine series, a third dose may be offered in some circumstances.
Public Funding	✅ Publicly funded for immunocompromised patients only ❌ Non-immunocompromised residents pay out of pocket. Qualifying conditions include use of corticosteroids or other immunosuppressive medication, autoimmune arthritis patients on biologics or DMARDs qualify. Residents pay approximately $30–50 at a pharmacy.
Where can I get vaccinated?	Immunocompromised patients: must book through Alberta Health Services (AHS) public health clinics ONLY (pharmacy access was removed as of fall 2025). Other residents: participating pharmacies.
Learn More	National Guidance Canadian Immunization Guide – COVID-19 Vaccine Alberta Alberta.ca – COVID-19 Information for Albertans Alberta Health Services – Find Healthcare

National Recommendation (National Advisory Committee on Immunization)	Influenza vaccination is recommended every year for everyone aged 6 months and older. People who are immunocompromised are a priority group and should receive a non-live influenza vaccine every year. The live attenuated influenza vaccine (FluMist®) is not recommended for people who are immunocompromised. High-dose flu vaccine or adjuvanted flu vaccines are recommended over standard-dose vaccines for adults aged 65 years and older.
Public Funding	✅ Publicly funded for all Albertans aged 6 months and older. The high-dose vaccine is funded for adults 65 and older through Long Term Care outreach programs. Adults who are immunocompromised and under age 65 receive the standard-dose vaccine, no enhanced-dose funding is available for this group.
Where can I get vaccinated?	Participating pharmacies Primary care provider AHS public health clinics
Learn More:	National Guidance Canadian Immunization Guide – Influenza Vaccine Alberta Alberta Health Services – Routine Immunization Schedule

National Recommendation (National Advisory Committee on Immunization)	Shingles vaccine is strongly recommended for all adults aged 18 years and older who are immunocompromised. It is also recommended for adults aged 50 years and older. The vaccine is given as a two-dose series, with the second dose typically administered 2 to 6 months after the first. For people who are immunocompromised, the interval may be shortened to as little as 4 weeks if needed.
Public Funding	✅ Publicly funded for adults aged 18 and older who have had or are preparing to have an organ transplant, or who have received a stem-cell transplant or Autologous hematopoietic stem-cell transplant recipients. ❌ Not publicly funded for autoimmune arthritis, biologic, or DMARD (disease modifying anti-rheumatic drug) patients. Cost is approximately $200–400 per dose out-of-pocket. Immunocompromised adults 50 and older are considered on a case-by-case basis, but this is not a funded program.
Where can I get vaccinated?	Community pharmacies (private purchase) Solid Organ Transplantation / Hematopoietic Stem Cell Transplantation patients via Alberta Immunization Policy Primary care provider
Learn More:	National Guidance Canadian Immunization Guide – Shingles Alberta Alberta Immunization Policy – Herpes Zoster (Shingrix)

National Recommendation (National Advisory Committee on Immunization)	RSV vaccination is recommended for adults aged 75 years and older. Adults aged 60 to 74 years who are at increased risk of severe RSV disease may also benefit from vaccination. Adults aged 75 years and older who have received a hematopoietic stem cell transplant should receive RSV vaccination.
Public Funding	✅ Indigenous person age 60 years or older and pregnant individuals at 32–36 weeks. ✅ Publicly funded for all adults aged 70+. ✅ If you are age 60 years or older and live in a continuing care or supportive living facility, you will be offered the RSV vaccine free of charge at your facility. ⚠️High-risk adults 19 to 69 who have had a lung transplant, a hematopoietic stem cell transplant, are on home oxygen or require chronic oxygen therapy or are receiving oxygen. (effective October 1, 2026) ❌ Autoimmune arthritis patients under age 70 (non-Indigenous) or under 60 (Indigenous) are not publicly funded.
Where can I get vaccinated?	Book online at a community pharmacy through the Alberta Vaccine Booking System. Alberta Health Service outreach and Long-term Care programs Participating pharmacies
Learn More:	National Guidance Canadian Immunization Guide – RSV Vaccine Alberta Alberta Immunization Policy – RSV Respiratory virus season – Get vaccinated

National Recommendation (National Advisory Committee on Immunization)	Pneu-C-20 or Pneu-C-21 is recommended for adults aged 65 years and older. Pneu-C-20 or Pneu-C-21 is also recommended for adults of any age who are immunocompromised or receiving immunosuppressive therapy. Most adults require one dose. If you have previously received an older pneumococcal vaccine (such as Pneu-P-23), you may still be eligible for Pneu-C-20. Speak with your healthcare provider about the schedule that is right for you.
Public Funding	✅Pneu-C-20 is publicly funded for adults 65 and older (with no prior Pneu-P-23/C-20). ✅Pneu-C-20 is publicly funded for immunocompromised adults aged 18–64. People taking eligible immunosuppressive therapies may qualify under the high-risk criteria; confirm eligibility with a healthcare provider or public health.
Where can I get vaccinated?	Participating pharmacies Primary care provider
Learn More:	National Guidance Canadian Immunization Guide – Pneumococcal Vaccine Alberta Pneumococcal conjugate 20 (PNEU-20) vaccine Alberta Immunization Policy – Pneu-C-20

National Recommendation (National Advisory Committee on Immunization)	HPV vaccination is recommended for everyone aged 9–26. Adults aged 27 and older may receive HPV vaccination following discussion and shared decision-making with a healthcare provider. If HPV vaccination is recommended for someone who is immunocompromised or living with HIV, a three-dose schedule is recommended, regardless of age. The usual schedule is: Dose 1: Day 0 Dose 2: 2 months after the first dose Dose 3: 6 months after the first dose
Public Funding	✅ Publicly funded for adults under 27 years of age. ⚠️ Immunocompromised adults 27 and older are not explicitly funded except for hematopoietic stem-cell recipients and solid-organ transplant candidates and recipients.
Where can I get vaccinated?	Participating pharmacies Routine school vaccination, normally offered in grade 6 Primary care provider
Learn More:	National Guidance Canadian Immunization Guide – HPV Vaccine Alberta Alberta Health Services – Adult Immunization Schedule Routine Immunization Schedule Standard on Immunization Recommendations for Specific Populations (Immunosuppressed and Chronic Health Conditions)

Saskatchewan

National Recommendation (National Advisory Committee on Immunization)	Most people for whom COVID-19 vaccination is recommended receive one dose per year. People who are moderately to severely immunocompromised are recommended to receive two COVID-19 vaccine doses each year, generally one in the fall and another in the spring. For people starting or restarting a COVID-19 vaccine series, a third dose may be offered in some circumstances.
Public Funding	⚠️ Publicly funded on a time-limited and shifting basis. The fall program was publicly funded for all residents 6 months and older, but ended March 31, 2026. The spring extra dose (April 1 – June 15, 2026) was free for immunocompromised individuals 6 months and older, adults 65 and older, and Long Term Care residents. After June 15, 2026, public funding is limited to adult transplant patients only, accessed through public health offices.
Where can I get vaccinated?	SHA Patient Booking (booking.saskhealthauthority.ca) Participating pharmacies (during the fall program) Phone: 1-833-727-5829
Learn More	National Guidance Canadian Immunization Guide – COVID-19 Vaccine Saskatchewan Saskatchewan Health Authority – COVID-19 Immunization Eligibility

National Recommendation (National Advisory Committee on Immunization)	Influenza vaccination is recommended every year for everyone aged 6 months and older. People who are immunocompromised are a priority group and should receive a non-live influenza vaccine every year. The live attenuated influenza vaccine (FluMist®) is not recommended for people who are immunocompromised. High-dose flu vaccine or adjuvanted flu vaccines are recommended over standard-dose vaccines for adults aged 65 years and older.
Public Funding	✅ Publicly funded for all Saskatchewan residents aged 6 months and older. ✅ The enhanced dose vaccine is funded for adults 65 and older. Immunocompromised adults under 65 receive the standard-dose vaccine only.
Where can I get vaccinated?	Participating pharmacies Primary care provider Saskatchewan public health offices
Learn More:	National Guidance Canadian Immunization Guide – Influenza Vaccine Saskatchewan eHealth Saskatchewan – Influenza and COVID-19 Immunization FAQs

National Recommendation (National Advisory Committee on Immunization)	Shingles vaccine is strongly recommended for all adults aged 18 years and older who are immunocompromised. It is also recommended for adults aged 50 years and older. The vaccine is given as a two-dose series, with the second dose typically administered 2 to 6 months after the first. For people who are immunocompromised, the interval may be shortened to as little as 4 weeks if needed.
Public Funding	✅ Publicly funded for adult solid-organ transplant candidates and recipients, adult autologous and allogeneic hematopoietic stem-cell transplant recipients, and adults who have received CAR T-cell therapy. Publicly funded for adult transplant patients ONLY, newly added in the 2025–26 budget. ❌Autoimmune arthritis, biologic, and DMARD (disease modifying antirheumatic drugs) patients are not publicly funded. Cost is approximately $200–400 per dose out-of-pocket (roughly $400–600 for the two-dose series) for those who don’t qualify.
Where can I get vaccinated?	Community pharmacies (private purchase) Primary care provider (transplant patients only, for funded access)
Learn More:	National Guidance Canadian Immunization Guide – Shingles Saskatchewan eHealth Saskatchewan – Saskatchewan Immunization Manual Amendments

National Recommendation (National Advisory Committee on Immunization)	RSV vaccination is recommended for adults aged 75 years and older. Adults aged 60 to 74 years who are at increased risk of severe RSV disease may also benefit from vaccination. Adults aged 75 years and older who have received a hematopoietic stem cell transplant should receive RSV vaccination.
Public Funding	✅ Effective August 24, 2026, publicly funded for adults aged 60 years and older living in: Long-term-care homes Personal-care homes ❌ Not publicly funded for community-dwelling adults in Saskatchewan. Cost is approximately $200–300 per dose out-of-pocket.
Where can I get vaccinated?	Community pharmacies (private purchase)
Learn More:	National Guidance Canadian Immunization Guide – RSV Vaccine Saskatchewan eHealth Saskatchewan – Saskatchewan Immunization Manual Amendments

National Recommendation (National Advisory Committee on Immunization)	Pneu-C-20 or Pneu-C-21 is recommended for adults aged 65 years and older. Pneu-C-20 or Pneu-C-21 is also recommended for adults of any age who are immunocompromised or receiving immunosuppressive therapy. Most adults require one dose. If you have previously received an older pneumococcal vaccine (such as Pneu-P-23), you may still be eligible for Pneu-C-20. Speak with your healthcare provider about the schedule that is right for you.
Public Funding	✅Pneu-C-21 is publicly funded for adults 65 and older (no prior pneumococcal vaccine). ✅ Pneu-C-21 is publicly funded for high-risk immunocompromised adults aged 18–64. Autoimmune arthritis patients on immunosuppressive therapy should qualify for Pneu-C-21.
Where can I get vaccinated?	Participating pharmacies Primary care provider
Learn More:	National Guidance Canadian Immunization Guide – Pneumococcal Vaccine Saskatchewan Publicly funded Pneumococcal Conjugate 21 Vaccine

National Recommendation (National Advisory Committee on Immunization)	HPV vaccination is recommended for everyone aged 9–26. Adults aged 27 and older may receive HPV vaccination following discussion and shared decision-making with a healthcare provider. If HPV vaccination is recommended for someone who is immunocompromised or living with HIV, a three-dose schedule is recommended, regardless of age. The usual schedule is: Dose 1: Day 0 Dose 2: 2 months after the first dose Dose 3: 6 months after the first dose
Public Funding	✅Publicly funded for adults under 27 years of age. ⚠️ Immunocompromised adults 27 and older are not explicitly funded.
Where can I get vaccinated?	Participating pharmacies Primary care provider
Learn More:	National Guidance Canadian Immunization Guide – HPV Vaccine Saskatchewan eHealth Saskatchewan – Saskatchewan Immunization Manual Amendments l Saskatchewan Health Authority – Immunization

Manitoba

National Recommendation (National Advisory Committee on Immunization)	Most people for whom COVID-19 vaccination is recommended receive one dose per year. People who are moderately to severely immunocompromised are recommended to receive two COVID-19 vaccine doses each year, generally one in the fall and another in the spring. For people starting or restarting a COVID-19 vaccine series, a third dose may be offered in some circumstances.
Public Funding	✅ Publicly funded for all Manitoba residents aged 6 months and older (annual dose). The spring extra dose (May 1 – June 30, 2026) is free for immunocompromised individuals 6 months and older, adults 65 and older, Indigenous individuals 45 and older, and Long Term Care residents. ⚠️ Manitoba’s definition of “immunocompromised” for the spring dose is narrower and less specific than other provinces, autoimmune arthritis and biologic patients may fall in a grey zone. Confirm eligibility with your provider.
Where can I get vaccinated?	Participating pharmacies (no prescription required) Public health nursing offices
Learn More	National Guidance Canadian Immunization Guide – COVID-19 Vaccine Manitoba Manitoba – COVID-19 Vaccine Manitoba – Vaccine Eligibility

National Recommendation (National Advisory Committee on Immunization)	Influenza vaccination is recommended every year for everyone aged 6 months and older. People who are immunocompromised are a priority group and should receive a non-live influenza vaccine every year. The live attenuated influenza vaccine (FluMist®) is not recommended for people who are immunocompromised. High-dose flu vaccine or adjuvanted flu vaccines are recommended over standard-dose vaccines for adults aged 65 years and older.
Public Funding	✅ Publicly funded for all Manitoba residents aged 6 months and older. Manitoba applies a “once eligible, always eligible” policy. Immunocompromised adults under 65 receive the standard-dose vaccine.
Where can I get vaccinated?	Participating pharmacies Primary care provider Public health offices
Learn More:	National Guidance Canadian Immunization Guide – Influenza Vaccine Manitoba Manitoba – Vaccine Eligibility

National Recommendation (National Advisory Committee on Immunization)	Shingles vaccine is strongly recommended for all adults aged 18 years and older who are immunocompromised. It is also recommended for adults aged 50 years and older. The vaccine is given as a two-dose series, with the second dose typically administered 2 to 6 months after the first. For people who are immunocompromised, the interval may be shortened to as little as 4 weeks if needed.
Public Funding	❌ Not publicly funded in Manitoba. There is no provincial shingles program. Cost is approximately $200–400 per dose out-of-pocket. Eligible First Nations and Inuit adults aged 60 years and older may receive coverage through the Non-Insured Health Benefits (NIHB) program.
Where can I get vaccinated?	Community pharmacies (private purchase; a prescription is needed)
Learn More:	National Guidance Canadian Immunization Guide – Shingles Manitoba Community pharmacies (private purchase)

National Recommendation (National Advisory Committee on Immunization)	RSV vaccination is recommended for adults aged 75 years and older. Adults aged 60 to 74 years who are at increased risk of severe RSV disease may also benefit from vaccination. Adults aged 75 years and older who have received a hematopoietic stem cell transplant should receive RSV vaccination.
Public Funding	✅ Beginning October 1, 2026, all individuals 80 years of age and older are eligible to receive one lifetime dose of the RSV vaccine. ✅ Individuals aged 60 to 79 years of age are eligible for one lifetime dose of the RSV vaccine if they: Reside in a personal care home (PCH), or Have been admitted to a PCH for respite care, or Have been admitted to a transitional care unit AND have been paneled for PCH and are awaiting placement, or Have been admitted to a chronic care unit AND have been paneled for PCH. ❌ Autoimmune arthritis patients living in the community are not publicly funded.
Where can I get vaccinated?	Via personal care home / Long-Term Care facility administration (for eligible residents)
Learn More:	National Guidance Canadian Immunization Guide – RSV Vaccine Manitoba Manitoba – Vaccine Eligibility

National Recommendation (National Advisory Committee on Immunization)	Pneu-C-20 or Pneu-C-21 is recommended for adults aged 65 years and older. Pneu-C-20 or Pneu-C-21 is also recommended for adults of any age who are immunocompromised or receiving immunosuppressive therapy. Most adults require one dose. If you have previously received an older pneumococcal vaccine (such as Pneu-P-23), you may still be eligible for Pneu-C-20. Speak with your healthcare provider about the schedule that is right for you.
Public Funding	✅ Publicly funded for adults 65 and older and high-risk adults of any age. Manitoba’s high-risk list explicitly includes “immunosuppressive therapy including use of long-term corticosteroids, post-organ transplant therapy, and certain anti-rheumatic drugs.” Autoimmune arthritis patients on DMARDs, biologics, or corticosteroids qualify.
Where can I get vaccinated?	Participating pharmacies Primary care provider Public health offices
Learn More:	National Guidance Canadian Immunization Guide – Pneumococcal Vaccine Manitoba Manitoba – Vaccine Eligibility

National Recommendation (National Advisory Committee on Immunization)	HPV vaccination is recommended for everyone aged 9–26. Adults aged 27 and older may receive HPV vaccination following discussion and shared decision-making with a healthcare provider. If HPV vaccination is recommended for someone who is immunocompromised or living with HIV, a three-dose schedule is recommended, regardless of age. The usual schedule is: Dose 1: Day 0 Dose 2: 2 months after the first dose Dose 3: 6 months after the first dose
Public Funding	✅Publicly funded for adults under 27 years of age. ⚠️Additional high-risk public funding applies to people with certain congenital or acquired immune deficiencies. This includes males aged 9–26 and females aged 9–45 who are pre- or post-solid-organ transplant, hematopoietic stem-cell transplant recipients or CAR T-cell therapy recipients. ❌ Autoimmune arthritis and biologic patients are not explicitly listed as a qualifying immunocompromised condition for HPV funding in Manitoba.
Where can I get vaccinated?	Public health offices Primary care provider (a prescription is required outside the school-based program)
Learn More:	National Guidance Canadian Immunization Guide – HPV Vaccine Manitoba CancerCare Manitoba – HPV Vaccine

Ontario

National Recommendation (National Advisory Committee on Immunization)	Most people for whom COVID-19 vaccination is recommended receive one dose per year. People who are moderately to severely immunocompromised are recommended to receive two COVID-19 vaccine doses each year, generally one in the fall and another in the spring. For people starting or restarting a COVID-19 vaccine series, a third dose may be offered in some circumstances.
Public Funding	✅ Publicly funded for eligible Ontario residents aged 6 months and older. ✅ Immunocompromised individuals receive an extra spring dose paid for by the government
Where can I get vaccinated?	Participating pharmacies (no prescription required) Primary care provider
Learn More	National Guidance Canadian Immunization Guide – COVID-19 Vaccine Ontario Ontario.ca – COVID-19 Vaccine Program

National Recommendation (National Advisory Committee on Immunization)	Influenza vaccination is recommended every year for everyone aged 6 months and older. People who are immunocompromised are a priority group and should receive a non-live influenza vaccine every year. The live attenuated influenza vaccine (FluMist®) is not recommended for people who are immunocompromised. High-dose flu vaccine or adjuvanted flu vaccines are recommended over standard-dose vaccines for adults aged 65 years and older.
Public Funding	✅ Publicly funded for all Ontario residents aged 6 months and older through the Universal Influenza Immunization Program (UIIP), no OHIP card required. The enhanced dose flu vaccines are funded for adults 65 and older. Immunocompromised adults under 65 receive the standard-dose vaccine only.
Where can I get vaccinated?	Participating pharmacies (no prescription required) Primary care provider, walk-in clinics
Learn More:	National Guidance Canadian Immunization Guide – Influenza Vaccine Ontario Ontario.ca – Universal Influenza Immunization Program

National Recommendation (National Advisory Committee on Immunization)	Shingles vaccine is strongly recommended for all adults aged 18 years and older who are immunocompromised. It is also recommended for adults aged 50 years and older. The vaccine is given as a two-dose series, with the second dose typically administered 2 to 6 months after the first. For people who are immunocompromised, the interval may be shortened to as little as 4 weeks if needed.
Public Funding	✅ Publicly funded for adults aged 65–70 ONLY. ❌ Autoimmune arthritis and biologic patients under 65 are not publicly funded. Cost is $150–200 per dose ($300–400 for the two-dose series), per the Ontario Rheumatology Association. A prescription may be required at some pharmacies.
Where can I get vaccinated?	Participating pharmacies (a prescription may be required) Primary care provider Walk-in clinics
Learn More:	National Guidance Canadian Immunization Guide – Shingles Ontario Ontario.ca – Shingles Vaccine

National Recommendation (National Advisory Committee on Immunization)	RSV vaccination is recommended for adults aged 75 years and older. Adults aged 60 to 74 years who are at increased risk of severe RSV disease may also benefit from vaccination. Adults aged 75 years and older who have received a hematopoietic stem cell transplant should receive RSV vaccination.
Public Funding	✅ Publicly funded for all adults 75 and older, and for adults 60–74 in specific high-risk groups: Long Term Care/retirement home residents, Alternate Level of Care patients those with glomerulonephritis (GN) and moderate-to-severe immunocompromised dialysis patients, solid organ/stem cell transplant recipients, individuals experiencing homelessness, and First Nations/Inuit/Métis individuals. ❌ Autoimmune arthritis and biologic patients aged 60–74 are not listed as a qualifying immunocompromised criterion. If not covered by public funding, cost is approximately $200–300 per dose.
Where can I get vaccinated?	Participating pharmacies (for eligible groups) Primary care provider, Long-term Care facility administration
Learn More:	National Guidance Canadian Immunization Guide – RSV Vaccine Ontario Ontario.ca – RSV Prevention Programs

National Recommendation (National Advisory Committee on Immunization)	Pneu-C-20 or Pneu-C-21 is recommended for adults aged 65 years and older. Pneu-C-20 or Pneu-C-21 is also recommended for adults of any age who are immunocompromised or receiving immunosuppressive therapy. Most adults require one dose. If you have previously received an older pneumococcal vaccine (such as Pneu-P-23), you may still be eligible for Pneu-C-20. Speak with your healthcare provider about the schedule that is right for you.
Public Funding	✅ Publicly funded for adults 65 and older (no prior Pneu-P-23) ✅ Publicly funded for high-risk adults of any age. Per the Ontario Rheumatology Association, this vaccine is “covered by OHIP for likely all rheumatology immunocompromised” patients. Autoimmune arthritis patients on immunosuppressive therapy should qualify for public funding.
Where can I get vaccinated?	Participating pharmacies Primary care provider Walk-in clinics
Learn More:	National Guidance Canadian Immunization Guide – Pneumococcal Vaccine Ontario Ontario.ca – Vaccines for Adults

National Recommendation (National Advisory Committee on Immunization)	HPV vaccination is recommended for everyone aged 9–26. Adults aged 27 and older may receive HPV vaccination following discussion and shared decision-making with a healthcare provider. If HPV vaccination is recommended for someone who is immunocompromised or living with HIV, a three-dose schedule is recommended, regardless of age. The usual schedule is: Dose 1: Day 0 Dose 2: 2 months after the first dose Dose 3: 6 months after the first dose
Public Funding	✅ Publicly funded and routinely offered in Grade 7. Catch-up vaccination through to Grade 12. ✅ A separate publicly funded program is available to gay, bisexual and other men who have sex with men up to age 26. ❌ Not publicly funded for adult catch-up in Ontario. ❌ Autoimmune arthritis patients on immunosuppressive therapy do not qualify for public funding. Cost is approximately $219 per dose (roughly $657 for the three-dose series required for immunocompromised patients), per the Ontario Rheumatology Association.
Where can I get vaccinated?	Participating pharmacies (a prescription may be required) Primary care provider, walk-in clinics
Learn More:	National Guidance Canadian Immunization Guide – HPV Vaccine Ontario Ontario.ca – Vaccines for Adults Getting the HPV vaccine

Quebec

National Recommendation (National Advisory Committee on Immunization)	Most people for whom COVID-19 vaccination is recommended receive one dose per year. People who are moderately to severely immunocompromised are recommended to receive two COVID-19 vaccine doses each year, generally one in the fall and another in the spring. For people starting or restarting a COVID-19 vaccine series, a third dose may be offered in some circumstances.
Public Funding	⚠️ Publicly funded for specific groups only. ✅ Publicly funded for immunocompromised individuals and those with chronic illness aged 6 months and older, adults 65 and older, health care workers, pregnant individuals, residents of remote regions, and CHSLD/RPA (Centre d’hébergement et de soins de longue durée/Résidence privée pour aînés) residents. ✅ Autoimmune arthritis patients with chronic illness or immunocompromised status should qualify for government coverage. Healthy adults aged 12–74 who don’t fall into a funded group pay $150–180 at a pharmacy.
Where can I get vaccinated?	Clic Santé booking (clicsante.ca) Participating pharmacies (free for eligible groups)
Learn More	National Guidance Canadian Immunization Guide – COVID-19 Vaccine Quebec Québec.ca – COVID-19 Vaccine

National Recommendation (National Advisory Committee on Immunization)	Influenza vaccination is recommended every year for everyone aged 6 months and older. People who are immunocompromised are a priority group and should receive a non-live influenza vaccine every year. The live attenuated influenza vaccine (FluMist®) is not recommended for people who are immunocompromised. High-dose flu vaccine or adjuvanted flu vaccines are recommended over standard-dose vaccines for adults aged 65 years and older.
Public Funding	✅ Publicly funded on request for all residents aged 6 months and older.
Where can I get vaccinated?	Participating pharmacies Primary care provider Centre local de services communautaires (CLSC)
Learn More:	National Guidance Canadian Immunization Guide – Influenza Vaccine Quebec Québec.ca – Flu (Influenza) Vaccine

National Recommendation (National Advisory Committee on Immunization)	Shingles vaccine is strongly recommended for all adults aged 18 years and older who are immunocompromised. It is also recommended for adults aged 50 years and older. The vaccine is given as a two-dose series, with the second dose typically administered 2 to 6 months after the first. For people who are immunocompromised, the interval may be shortened to as little as 4 weeks if needed.
Public Funding	✅ Publicly funded for adults 71 and older AND for immunocompromised adults 18 and older. ✅ Autoimmune arthritis patients on biologics, DMARDs (disease-modifying antirheumatic drugs), or JAK inhibitors should qualify as Immunocompromised at 18 and older.
Where can I get vaccinated?	Centre local de services communautaires (CLSC) Community pharmacies Primary care provider
Learn More:	National Guidance Canadian Immunization Guide – Shingles Quebec Québec.ca – Shingles Vaccination Program Definition of Immunocompromised in Quebec

National Recommendation (National Advisory Committee on Immunization)	RSV vaccination is recommended for adults aged 75 years and older. Adults aged 60 to 74 years who are at increased risk of severe RSV disease may also benefit from vaccination. Adults aged 75 years and older who have received a hematopoietic stem cell transplant should receive RSV vaccination.
Public Funding	✅ Quebec’s 2025–2026 publicly funded RSV vaccination campaign ended on May 18, 2026. During that campaign, free vaccination was available to: People aged 60 and older living in a long-term care home (CHSLD) or intermediate residential care setting (RI), or receiving services through the Support for the Autonomy of Older Adults program (SAPA) People aged 75 and older living in a category 3 or 4 private seniors’ residence (RPA) ❌ Not publicly funded for adults with immunocompromised status, including transplant patients, Quebec’s own materials describe it as “recommended but not offered free” for this group. Cost is approximately $200–300 per dose out-of-pocket.
Where can I get vaccinated?	Community pharmacies (private purchase) Primary care provider
Learn More:	National Guidance Canadian Immunization Guide – RSV Vaccine Quebec Québec.ca – RSV Immunization

National Recommendation (National Advisory Committee on Immunization)	Pneu-C-20 or Pneu-C-21 is recommended for adults aged 65 years and older. Pneu-C-20 or Pneu-C-21 is also recommended for adults of any age who are immunocompromised or receiving immunosuppressive therapy. Most adults require one dose. If you have previously received an older pneumococcal vaccine (such as Pneu-P-23), you may still be eligible for Pneu-C-20. Speak with your healthcare provider about the schedule that is right for you.
Public Funding	✅ Publicly funded for adults 65 and older (using Pneu-C-21) ✅Publicly funded for high-risk immunocompromised adults of any age.
Where can I get vaccinated?	Centre local de services communautaires (CLSC) Book through Clic Santé, or call 1-877-644-4545. Community pharmacies Primary care provider
Learn More:	National Guidance Canadian Immunization Guide – Pneumococcal Vaccine Quebec Québec.ca – Pneumococcal Vaccine Pneu-C : vaccin conjugué contre le pneumocoque Vaccinologie pratique – Immunodépression

National Recommendation (National Advisory Committee on Immunization)	HPV vaccination is recommended for everyone aged 9–26. Adults aged 27 and older may receive HPV vaccination following discussion and shared decision-making with a healthcare provider. If HPV vaccination is recommended for someone who is immunocompromised or living with HIV, a three-dose schedule is recommended, regardless of age. The usual schedule is: Dose 1: Day 0 Dose 2: 2 months after the first dose Dose 3: 6 months after the first dose
Public Funding	✅ Publicly funded and routinely offered in Grade 4. Catch-up vaccination through to age 20. ✅Publicly funded for people aged 21–45 who have a weakened immune system or live with HIV. ❌Immunocompromised adults 21 and older are not publicly funded and must pay privately.
Where can I get vaccinated?	Centre local de services communautaires (CLSC) School-based programs
Learn More:	National Guidance Canadian Immunization Guide – HPV Vaccine Quebec Québec.ca – HPV Vaccination Program

New Brunswick

National Recommendation (National Advisory Committee on Immunization)	Most people for whom COVID-19 vaccination is recommended receive one dose per year. People who are moderately to severely immunocompromised are recommended to receive two COVID-19 vaccine doses each year, generally one in the fall and another in the spring. For people starting or restarting a COVID-19 vaccine series, a third dose may be offered in some circumstances.
Public Funding	✅ Publicly funded for all New Brunswick residents aged 6 months and older. The spring extra dose (available until June 26, 2026) is publicly funded for immunocompromised individuals 6 months and older, adults 65 and older, and Long Term Care residents.
Where can I get vaccinated?	Participating pharmacies Primary care provider Public health offices/clinics
Learn More	National Guidance Canadian Immunization Guide – COVID-19 Vaccine New Brunswick Government of New Brunswick – COVID-19 Spring Booster

National Recommendation (National Advisory Committee on Immunization)	Influenza vaccination is recommended every year for everyone aged 6 months and older. People who are immunocompromised are a priority group and should receive a non-live influenza vaccine every year. The live attenuated influenza vaccine (FluMist®) is not recommended for people who are immunocompromised. High-dose flu vaccine or adjuvanted flu vaccines are recommended over standard-dose vaccines for adults aged 65 years and older.
Public Funding	✅ Publicly funded for all New Brunswick residents aged 6 months and older, from October 1 through July 31 annually. Pharmacists may administer the vaccine from age 2 onward.
Where can I get vaccinated?	Participating pharmacies (age 2 and older) Primary care provider Public health offices
Learn More:	National Guidance Canadian Immunization Guide – Influenza Vaccine New Brunswick Government of New Brunswick – Publicly Funded Seasonal Influenza Vaccine 2025–2026

National Recommendation (National Advisory Committee on Immunization)	Shingles vaccine is strongly recommended for all adults aged 18 years and older who are immunocompromised. It is also recommended for adults aged 50 years and older. The vaccine is given as a two-dose series, with the second dose typically administered 2 to 6 months after the first. For people who are immunocompromised, the interval may be shortened to as little as 4 weeks if needed.
Public Funding	❌ Not publicly funded in New Brunswick. There is no provincial shingles program. Cost is approximately $200–400 per dose out-of-pocket. Eligible First Nations and Inuit adults aged 60 years and older may receive coverage through the Non-Insured Health Benefits (NIHB) program.
Where can I get vaccinated?	Community pharmacies (private purchase)
Learn More:	National Guidance Canadian Immunization Guide – Shingles New Brunswick New Brunswick Immunization Schedule

National Recommendation (National Advisory Committee on Immunization)	RSV vaccination is recommended for adults aged 75 years and older. Adults aged 60 to 74 years who are at increased risk of severe RSV disease may also benefit from vaccination. Adults aged 75 years and older who have received a hematopoietic stem cell transplant should receive RSV vaccination.
Public Funding	✅ Publicly funded for adults 75 and older. ✅ Publicly funded only for adults 60 and older living in Long-Term Care/Community Care facilities or receiving alternate level of care or awaiting long-term care placement. ✅Publicly funded for Indigenous people aged 60+. ✅60 years of age and older in rehabilitation units within hospitals ❌ Autoimmune arthritis patients under 75 are not publicly funded. Cost is approximately $200–300 per dose out-of-pocket for those who don’t qualify.
Where can I get vaccinated?	Participating pharmacies Primary care provider
Learn More:	National Guidance Canadian Immunization Guide – RSV Vaccine New Brunswick New Brunswick Immunization Schedule

National Recommendation (National Advisory Committee on Immunization)	Pneu-C-20 or Pneu-C-21 is recommended for adults aged 65 years and older. Pneu-C-20 or Pneu-C-21 is also recommended for adults of any age who are immunocompromised or receiving immunosuppressive therapy. Most adults require one dose. If you have previously received an older pneumococcal vaccine (such as Pneu-P-23), you may still be eligible for Pneu-C-20. Speak with your healthcare provider about the schedule that is right for you.
Public Funding	✅ Publicly funded for adults 65 and older (no prior Pneu-P-23) ✅ Publicly funded for immunocompromised high-risk adults of any age. Autoimmune arthritis patients on immunosuppressive therapy should qualify.
Where can I get vaccinated?	Participating pharmacies Primary care provider Public health offices
Learn More:	National Guidance Canadian Immunization Guide – Pneumococcal Vaccine New Brunswick Government of New Brunswick – Eligibility Criteria for Publicly Funded Vaccines and Biologics

National Recommendation (National Advisory Committee on Immunization)	HPV vaccination is recommended for everyone aged 9–26. Adults aged 27 and older may receive HPV vaccination following discussion and shared decision-making with a healthcare provider. If HPV vaccination is recommended for someone who is immunocompromised or living with HIV, a three-dose schedule is recommended, regardless of age. The usual schedule is: Dose 1: Day 0 Dose 2: 2 months after the first dose Dose 3: 6 months after the first dose
Public Funding	✅ Publicly funded for routine vaccination from age 9 through 26, subject to the applicable sex/birth-cohort program rules. ✅ Publicly funded for immunocompromised adults aged 18–45. The detailed table is not available for confirmation. ✅ Publicly funded for people identifying as gay, bisexual or other men who have sex with men aged 18 – 45.
Where can I get vaccinated?	Participating pharmacies Primary care provider
Learn More:	National Guidance Canadian Immunization Guide – HPV Vaccine New Brunswick Government of New Brunswick – Human Papillomavirus (HPV) Vaccine Government of New Brunswick – Public Health Services Eligibility Criteria for Publicly Funded Vaccines/Biologics in New Brunswick

Nova Scotia

National Recommendation (National Advisory Committee on Immunization)	Most people for whom COVID-19 vaccination is recommended receive one dose per year. People who are moderately to severely immunocompromised are recommended to receive two COVID-19 vaccine doses each year, generally one in the fall and another in the spring. For people starting or restarting a COVID-19 vaccine series, a third dose may be offered in some circumstances.
Public Funding	✅ Publicly funded for all Nova Scotia residents aged 6 months and older. The spring extra dose (until June 30, 2026) is strongly encouraged for immunocompromised individuals 6 months and older, adults 80 and older, Long Term Care residents, adults 65 and older, and First Nations/Black Nova Scotian individuals 50 and older.
Where can I get vaccinated?	Participating pharmacies Primary care provider NS Health public health offices/clinics
Learn More	National Guidance Canadian Immunization Guide – COVID-19 Vaccine Nova Scotia NS Health – COVID-19 Vaccine

National Recommendation (National Advisory Committee on Immunization)	Influenza vaccination is recommended every year for everyone aged 6 months and older. People who are immunocompromised are a priority group and should receive a non-live influenza vaccine every year. The live attenuated influenza vaccine (FluMist®) is not recommended for people who are immunocompromised. High-dose flu vaccine or adjuvanted flu vaccines are recommended over standard-dose vaccines for adults aged 65 years and older.
Public Funding	✅ Publicly funded for all Nova Scotia residents aged 6 months and older. ✅Enhanced dose is publicly funded for adults 65 and older. Immunocompromised adults under 65 receive the standard-dose vaccine.
Where can I get vaccinated?	Participating pharmacies Primary care provider Public health offices
Learn More:	National Guidance Canadian Immunization Guide – Influenza Vaccine Nova Scotia Nova Scotia – Routine Immunization Schedules for Children, Youth and Adults

National Recommendation (National Advisory Committee on Immunization)	Shingles vaccine is strongly recommended for all adults aged 18 years and older who are immunocompromised. It is also recommended for adults aged 50 years and older. The vaccine is given as a two-dose series, with the second dose typically administered 2 to 6 months after the first. For people who are immunocompromised, the interval may be shortened to as little as 4 weeks if needed.
Public Funding	✅Publicly funded for adults 65 and older. ❌ Not publicly funded for autoimmune arthritis and biologic patients under 65. Shingles is not listed in Nova Scotia’s high-risk immunocompromised eligibility table. Cost is approximately $200–400 per dose.
Where can I get vaccinated?	Community pharmacies Primary care provider Long-term Care facilities
Learn More:	National Guidance Canadian Immunization Guide – Shingles Nova Scotia Nova Scotia – Vaccine Eligibility for High-Risk Conditions Nova Scotia announcement – May 2025

National Recommendation (National Advisory Committee on Immunization)	RSV vaccination is recommended for adults aged 75 years and older. Adults aged 60 to 74 years who are at increased risk of severe RSV disease may also benefit from vaccination. Adults aged 75 years and older who have received a hematopoietic stem cell transplant should receive RSV vaccination.
Public Funding	✅ Publicly funded only for adults 60 and older living in Long-Term Care/Community Care facilities, or hospitalized and awaiting placement in long-term care facilities. ✅ Publicly funded for those age 75 years of age and older. ❌ Not publicly funded for general adults or for most immunocompromised adults. Nova Scotia’s High-Risk Appendix A lists only eculizumab-acquired complement deficiency as a qualifying immunosuppressive condition for RSV, autoimmune arthritis and biologic patients do not qualify through any Nova Scotia pathway. Cost is approximately $200–300 per dose out-of-pocket.
Where can I get vaccinated?	Community pharmacies (private purchase) A prescription may be needed, but pharmacies can provide one
Learn More:	National Guidance Canadian Immunization Guide – RSV Vaccine Nova Scotia Seasonal Vaccines Nova Scotia – Vaccine Eligibility for High-Risk Conditions Nova Scotia – RSV vaccine for older adults

National Recommendation (National Advisory Committee on Immunization)	Pneu-C-20 or Pneu-C-21 is recommended for adults aged 65 years and older. Pneu-C-20 or Pneu-C-21 is also recommended for adults of any age who are immunocompromised or receiving immunosuppressive therapy. Most adults require one dose. If you have previously received an older pneumococcal vaccine (such as Pneu-P-23), you may still be eligible for Pneu-C-20. Speak with your healthcare provider about the schedule that is right for you.
Public Funding	✅ Publicly funded for adults 65 and older. ✅Publicly funded for immunocompromised high-risk adults of any age Nova Scotia’s Appendix A explicitly lists immunosuppressive therapy, including long-term corticosteroids, chemotherapy, radiation therapy, and post-organ transplant therapy, as a qualifying condition. Autoimmune arthritis patients on immunocompromising therapy should qualify.
Where can I get vaccinated?	Nova Scotia Health or call 811 (if over 65) Participating pharmacies Primary care provider
Learn More:	National Guidance Canadian Immunization Guide – Pneumococcal Vaccine Nova Scotia Nova Scotia Health – Immunizations Nova Scotia – Vaccine Eligibility for High-Risk Conditions

National Recommendation (National Advisory Committee on Immunization)	HPV vaccination is recommended for everyone aged 9–26. Adults aged 27 and older may receive HPV vaccination following discussion and shared decision-making with a healthcare provider. If HPV vaccination is recommended for someone who is immunocompromised or living with HIV, a three-dose schedule is recommended, regardless of age. The usual schedule is: Dose 1: Day 0 Dose 2: 2 months after the first dose Dose 3: 6 months after the first dose
Public Funding	✅ Publicly funded for routine school vaccination (grade 7). ✅Publicly funded for adults who missed the school vaccination up to age 21. ❌Immunocompromised adults 19 and older are not publicly funded and must pay privately.
Where can I get vaccinated?	School-based programs and public health offices (under 19) Community pharmacies (private purchase, 19 and older)
Learn More:	National Guidance Canadian Immunization Guide – HPV Vaccine Nova Scotia Nova Scotia – Vaccine Eligibility for High-Risk Conditions Nova Scotia – Immunization

Prince Edward Island

National Recommendation (National Advisory Committee on Immunization)	Most people for whom COVID-19 vaccination is recommended receive one dose per year. People who are moderately to severely immunocompromised are recommended to receive two COVID-19 vaccine doses each year, generally one in the fall and another in the spring. For people starting or restarting a COVID-19 vaccine series, a third dose may be offered in some circumstances.
Public Funding	✅ Publicly funded for all PEI residents aged 6 months and older. ✅ Immunocompromised individuals receive extra spring doses per National Advisory Committee on Immunization (NACI) guidance. PEI maintained universal access, aligned with NACI recommendations throughout 2025.
Where can I get vaccinated?	Participating pharmacies Public Health Nursing (PHN) offices Physician/nurse practitioner offices Obstetrical offices
Learn More	National Guidance Canadian Immunization Guide – COVID-19 Vaccine Prince Edward Island Government of PEI – Get a COVID-19 Vaccine

National Recommendation (National Advisory Committee on Immunization)	Influenza vaccination is recommended every year for everyone aged 6 months and older. People who are immunocompromised are a priority group and should receive a non-live influenza vaccine every year. The live attenuated influenza vaccine (FluMist®) is not recommended for people who are immunocompromised. High-dose flu vaccine or adjuvanted flu vaccines are recommended over standard-dose vaccines for adults aged 65 years and older.
Public Funding	✅ Publicly funded for all PEI residents aged 6 months and older. Available at multiple points of care.
Where can I get vaccinated?	PHN offices Participating pharmacies Physician/nurse practitioner offices Obstetrical offices
Learn More:	National Guidance Canadian Immunization Guide – Influenza Vaccine Prince Edward Island Government of PEI – Adult Immunizations

National Recommendation (National Advisory Committee on Immunization)	Shingles vaccine is strongly recommended for all adults aged 18 years and older who are immunocompromised. It is also recommended for adults aged 50 years and older. The vaccine is given as a two-dose series, with the second dose typically administered 2 to 6 months after the first. For people who are immunocompromised, the interval may be shortened to as little as 4 weeks if needed.
Public Funding	✅ Publicly funded for adults 50 and older (two-dose series); no referral is needed at pharmacies. ✅ People aged 18 to 49 with an immunocompromising condition are eligible for publicly funded Shingles vaccine. This may include immunosuppression caused by a medical condition or treatment.
Where can I get vaccinated?	Community pharmacies Primary care provider
Learn More:	National Guidance Canadian Immunization Guide – Shingles Prince Edward Island Government of PEI – Adult Immunizations Public Health Agency of Canada

National Recommendation (National Advisory Committee on Immunization)	RSV vaccination is recommended for adults aged 75 years and older. Adults aged 60 to 74 years who are at increased risk of severe RSV disease may also benefit from vaccination. Adults aged 75 years and older who have received a hematopoietic stem cell transplant should receive RSV vaccination.
Public Funding	✅ Publicly funded for those age 75 years of age and older ✅ Publicly funded for adults 60 and older living in Long-Term Care/Community Care facilities. ❌ Not publicly funded for immunocompromised adults, including people with autoimmune arthritis, living in the community
Where can I get vaccinated?	Via Long-Term Care / Community Care facility administration (for eligible residents 60 and older) Community pharmacies (private purchase for community-dwelling adults)
Learn More:	National Guidance Canadian Immunization Guide – RSV Vaccine Prince Edward Island Government of PEI – RSV Vaccine Fact Sheet

National Recommendation (National Advisory Committee on Immunization)	Pneu-C-20 or Pneu-C-21 is recommended for adults aged 65 years and older. Pneu-C-20 or Pneu-C-21 is also recommended for adults of any age who are immunocompromised or receiving immunosuppressive therapy. Most adults require one dose. If you have previously received an older pneumococcal vaccine (such as Pneu-P-23), you may still be eligible for Pneu-C-20. Speak with your healthcare provider about the schedule that is right for you.
Public Funding	✅ Publicly funded for adults 65 and older (no referral needed at PHN) and ✅ Publicly funded for high-risk adults under 65 with a health care provider referral to PHN. PEI explicitly lists qualifying immunocompromised conditions as “immunocompromising therapy including use of long-term corticosteroids (oral prednisone >2 weeks), chemotherapy, radiation therapy, post-organ transplant therapy and certain anti-rheumatic drugs.” Autoimmune arthritis patients on oral corticosteroids or anti-rheumatic drugs explicitly qualify.
Where can I get vaccinated?	Public Health Nursing offices (a referral is needed for adults under 65) Primary care provider
Learn More:	National Guidance Canadian Immunization Guide – Pneumococcal Vaccine Prince Edward Island Government of PEI – Adult Detailed Immunization Schedule

National Recommendation (National Advisory Committee on Immunization)	HPV vaccination is recommended for everyone aged 9–26. Adults aged 27 and older may receive HPV vaccination following discussion and shared decision-making with a healthcare provider. If HPV vaccination is recommended for someone who is immunocompromised or living with HIV, a three-dose schedule is recommended, regardless of age. The usual schedule is: Dose 1: Day 0 Dose 2: 2 months after the first dose Dose 3: 6 months after the first dose
Public Funding	✅ Publicly funded for routine school vaccination. ✅Publicly funded for adults age 18-26 ✅ Publicly funded for adults aged 27–45 with risk factors, like immune suppression. A public health nurse should confirm the case.
Where can I get vaccinated?	PHN offices Primary care provider
Learn More:	National Guidance Canadian Immunization Guide – HPV Vaccine Prince Edward Island Government of PEI – Adult Detailed Immunization Schedule Government of PEI – Recommended Adult Vaccines

Newfoundland and Labrador

National Recommendation (National Advisory Committee on Immunization)	Most people for whom COVID-19 vaccination is recommended receive one dose per year. People who are moderately to severely immunocompromised are recommended to receive two COVID-19 vaccine doses each year, generally one in the fall and another in the spring. For people starting or restarting a COVID-19 vaccine series, a third dose may be offered in some circumstances.
Public Funding	✅ Publicly funded for all NL residents aged 6 months and older. ✅Immunocompromised individuals receive extra spring doses per National Advisory Committee on Immunization (NACI) guidance.
Where can I get vaccinated?	Participating pharmacies Primary care provider Public health offices/clinics
Learn More	National Guidance Canadian Immunization Guide – COVID-19 Vaccine Newfoundland and Labrador Government of NL – COVID-19 Vaccine

National Recommendation (National Advisory Committee on Immunization)	Influenza vaccination is recommended every year for everyone aged 6 months and older. People who are immunocompromised are a priority group and should receive a non-live influenza vaccine every year. The live attenuated influenza vaccine (FluMist®) is not recommended for people who are immunocompromised. High-dose flu vaccine or adjuvanted flu vaccines are recommended over standard-dose vaccines for adults aged 65 years and older.
Public Funding	✅ Publicly funded for all NL residents aged 6 months and older. Enhanced (high-dose) flu vaccine is funded for adults 65 and older.
Where can I get vaccinated?	Participating pharmacies Primary care provider NLHS public health offices
Learn More:	National Guidance Canadian Immunization Guide – Influenza Vaccine Newfoundland and Labrador Government of NL – Influenza Immunization Release

National Recommendation (National Advisory Committee on Immunization)	Shingles vaccine is strongly recommended for all adults aged 18 years and older who are immunocompromised. It is also recommended for adults aged 50 years and older. The vaccine is given as a two-dose series, with the second dose typically administered 2 to 6 months after the first. For people who are immunocompromised, the interval may be shortened to as little as 4 weeks if needed.
Public Funding	✅ Publicly funded for all adults 50 and older, as of September 1, 2025. ✅ People aged 18 to 49 with an immunocompromising condition are eligible for publicly funded Shingles vaccine. This may include immunosuppression caused by a medical condition or treatment.
Where can I get vaccinated?	Community pharmacies Primary care provider NLHS public health offices
Learn More:	National Guidance Canadian Immunization Guide – Shingles Newfoundland and Labrador Government of NL – Shingles Vaccine Expansion Release Public Health Agency of Canada

National Recommendation (National Advisory Committee on Immunization)	RSV vaccination is recommended for adults aged 75 years and older. Adults aged 60 to 74 years who are at increased risk of severe RSV disease may also benefit from vaccination. Adults aged 75 years and older who have received a hematopoietic stem cell transplant should receive RSV vaccination.
Public Funding	✅Adults 75 years and older ✅Adults 60 years of age and older living in senior congregate living facilities ❌ Not publicly funded for immunocompromised adults living in the community ❌ Autoimmune arthritis patients in the community are not eligible.
Where can I get vaccinated?	Via congregate living facility administration (for eligible residents)
Learn More:	National Guidance Canadian Immunization Guide – RSV Vaccine Newfoundland and Labrador Government of NL – Immunization for the Protection Against Respiratory Syncytial Virus (RSV) Disease

National Recommendation (National Advisory Committee on Immunization)	Pneu-C-20 or Pneu-C-21 is recommended for adults aged 65 years and older. Pneu-C-20 or Pneu-C-21 is also recommended for adults of any age who are immunocompromised or receiving immunosuppressive therapy. Most adults require one dose. If you have previously received an older pneumococcal vaccine (such as Pneu-P-23), you may still be eligible for Pneu-C-20. Speak with your healthcare provider about the schedule that is right for you.
Public Funding	✅ Publicly funded for adults 65 and older ✅Publicly funded for high-risk adults 18 and older with eligible medical or environmental risk factor Pneu-C-13 and Pneu-P-23 were discontinued in NL as of June 2025, all pneumococcal vaccination is now delivered via Pneu-C-20. People taking eligible immunosuppressive therapies may qualify under the high-risk criteria; confirm eligibility with a healthcare provider or public health.
Where can I get vaccinated?	Participating pharmacies Primary care provider NLHS public health offices
Learn More:	National Guidance Canadian Immunization Guide – Pneumococcal Vaccine Newfoundland and Labrador Newfoundland and Labrador pneumococcal conjugate vaccine policy Government of NL – New Fee Codes for Adult Immunizations

National Recommendation (National Advisory Committee on Immunization)	HPV vaccination is recommended for everyone aged 9–26. Adults aged 27 and older may receive HPV vaccination following discussion and shared decision-making with a healthcare provider. If HPV vaccination is recommended for someone who is immunocompromised or living with HIV, a three-dose schedule is recommended, regardless of age. The usual schedule is: Dose 1: Day 0 Dose 2: 2 months after the first dose Dose 3: 6 months after the first dose
Public Funding	✅ Publicly funded for routine school vaccination (grade 6). ✅Publicly funded for adults who missed the school vaccinatoin up to age 20. ❌Immunocompromised adults 19 and older are not publicly funded and must pay privately.
Where can I get vaccinated?	Community pharmacies (private purchase) Primary care provider
Learn More:	National Guidance Canadian Immunization Guide – HPV Vaccine Newfoundland and Labrador Government of NL – Public Health Immunizations Government of NL – PROTECTION FROM HUMAN PAPILLOMAVIRUS (HPV)

Yukon

National Recommendation (National Advisory Committee on Immunization)	Most people for whom COVID-19 vaccination is recommended receive one dose per year. People who are moderately to severely immunocompromised are recommended to receive two COVID-19 vaccine doses each year, generally one in the fall and another in the spring. For people starting or restarting a COVID-19 vaccine series, a third dose may be offered in some circumstances.
Public Funding	✅ Publicly funded for all Yukon residents aged 6 months and older. Booking is available year-round.
Where can I get vaccinated?	Whitehorse Health Centre Participating pharmacies Book online at yukon.ca
Learn More	National Guidance Canadian Immunization Guide – COVID-19 Vaccine Yukon Yukon.ca – Book a Seasonal Immunization Appointment

National Recommendation (National Advisory Committee on Immunization)	Influenza vaccination is recommended every year for everyone aged 6 months and older. People who are immunocompromised are a priority group and should receive a non-live influenza vaccine every year. The live attenuated influenza vaccine (FluMist®) is not recommended for people who are immunocompromised. High-dose flu vaccine or adjuvanted flu vaccines are recommended over standard-dose vaccines for adults aged 65 years and older.
Public Funding	✅ Publicly funded for all Yukon residents aged 6 months and older. High-dose flu vaccine is funded for adults 65 and older.
Where can I get vaccinated?	Whitehorse pharmacies Community health centres
Learn More:	National Guidance Canadian Immunization Guide – Influenza Vaccine Yukon Yukon.ca – Yukon Immunization Program Manual: Influenza Vaccines

National Recommendation (National Advisory Committee on Immunization)	Shingles vaccine is strongly recommended for all adults aged 18 years and older who are immunocompromised. It is also recommended for adults aged 50 years and older. The vaccine is given as a two-dose series, with the second dose typically administered 2 to 6 months after the first. For people who are immunocompromised, the interval may be shortened to as little as 4 weeks if needed.
Public Funding	✅ Publicly funded for adults aged 65–79 (two-dose series). ✅ Immunocompromised individuals 18 years and older with an eligible condition or therapy, including: Primary immunodeficiencies affecting innate, humoral or T-cell immunity Hematopoietic stem-cell transplant Solid-organ transplant Hematological malignancy Solid-tumour malignancy while receiving immunosuppressive treatment HIV infection Chronic or ongoing immunosuppressive therapy, including: Immunosuppressive chemotherapy or radiation Calcineurin inhibitors, cytotoxic medications or antimetabolites Immune-effector cell therapy, including CAR-T therapy Biological-response modifiers, targeted therapies or antibodies affecting lymphocytes or immune pathways, including anti-CD20 agents, anti-TNF-alpha agents and JAK inhibitors Long-term high-dose systemic corticosteroids: at least 2 mg/kg/day, or at least 20 mg/day for someone over 10 kg, for at least 14 days Immunocompromised adults outside that age range are considered on a CASE-BY-CASE basis and must contact Yukon’s Chief Public Health Officer (CPHO), this is not a guaranteed funded program for Immunocompromised patients outside the 65–79 age window. Eligible First Nations and Inuit adults aged 60 years and older may also receive coverage through the Non-Insured Health Benefits (NIHB) program.
Where can I get vaccinated?	Whitehorse pharmacies and community health centres (for adults 65–79) For case-by-case Immunocompromised access: contact the CPHO at (867) 667-8343
Learn More:	National Guidance Canadian Immunization Guide – Shingles Yukon Yukon Immunize – Shingles Yukon.ca – Zoster Vaccine (Section 8)

National Recommendation (National Advisory Committee on Immunization)	RSV vaccination is recommended for adults aged 75 years and older. Adults aged 60 to 74 years who are at increased risk of severe RSV disease may also benefit from vaccination. Adults aged 75 years and older who have received a hematopoietic stem cell transplant should receive RSV vaccination.
Public Funding	✅ Publicly funded for all adults aged 65 years and older ✅ Publicly funded for adults 60 and older in Long Term Care ✅ Publicly funded for adults aged 18–64 at high risk of severe RSV illness, including people who: Live in long-term care or assisted living Have received a lung or hematopoietic stem-cell transplant Require long-term oxygen therapy Receive dialysis Have a history of bronchopulmonary dysplasia ❌ Not publicly funded for autoimmune arthritis, biologic, or DMARD (disease modifying anti-rheumatic drug) patients.
Where can I get vaccinated?	Whitehorse Health Centre Community health centres Long-term Care facilities
Learn More:	National Guidance Canadian Immunization Guide – RSV Vaccine Yukon Yukon.ca – Book a Seasonal Immunization Appointment

National Recommendation (National Advisory Committee on Immunization)	Pneu-C-20 or Pneu-C-21 is recommended for adults aged 65 years and older. Pneu-C-20 or Pneu-C-21 is also recommended for adults of any age who are immunocompromised or receiving immunosuppressive therapy. Most adults require one dose. If you have previously received an older pneumococcal vaccine (such as Pneu-P-23), you may still be eligible for Pneu-C-20. Speak with your healthcare provider about the schedule that is right for you.
Public Funding	✅ Publicly funded for adults 65 and older ✅ Publicly funded for high-risk immunocompromised adults of any age
Where can I get vaccinated?	Primary care provider Community health centres
Learn More:	National Guidance Canadian Immunization Guide – Pneumococcal Vaccine Yukon Yukon.ca – Immunization Schedules (Yukon Immunization Program Manual)

National Recommendation (National Advisory Committee on Immunization)	HPV vaccination is recommended for everyone aged 9–26. Adults aged 27 and older may receive HPV vaccination following discussion and shared decision-making with a healthcare provider. If HPV vaccination is recommended for someone who is immunocompromised or living with HIV, a three-dose schedule is recommended, regardless of age. The usual schedule is: Dose 1: Day 0 Dose 2: 2 months after the first dose Dose 3: 6 months after the first dose
Public Funding	✅ Publicly funded for adults under 27 ✅ Publicly funded for high-risk individuals from age 27-45 who live with HIV or are being followed for cervical dysplasia ❌ Not publicly funded for autoimmune arthritis, biologic, or DMARD (disease modifying anti-rheumatic drug) patients.
Where can I get vaccinated?	Participating pharmacies (no prescription required from age 9) Primary care provider
Learn More:	National Guidance Canadian Immunization Guide – HPV Vaccine Yukon Yukon Immunize – Human Papilloma Virtus (NPV) Yukon.ca – Find Yukon Immunization Information

Northwest Territories

National Recommendation (National Advisory Committee on Immunization)	Most people for whom COVID-19 vaccination is recommended receive one dose per year. People who are moderately to severely immunocompromised are recommended to receive two COVID-19 vaccine doses each year, generally one in the fall and another in the spring. For people starting or restarting a COVID-19 vaccine series, a third dose may be offered in some circumstances.
Public Funding	✅ Publicly funded for all NWT residents per NACI guidance. Immunocompromised and other high-risk groups are explicitly included.
Where can I get vaccinated?	Community health centres Regional health authorities
Learn More	National Guidance Canadian Immunization Guide – COVID-19 Vaccine Northwest Territories Government of NWT – COVID-19

National Recommendation (National Advisory Committee on Immunization)	Influenza vaccination is recommended every year for everyone aged 6 months and older. People who are immunocompromised are a priority group and should receive a non-live influenza vaccine every year. The live attenuated influenza vaccine (FluMist®) is not recommended for people who are immunocompromised. High-dose flu vaccine or adjuvanted flu vaccines are recommended over standard-dose vaccines for adults aged 65 years and older.
Public Funding	✅ Publicly funded for all NWT residents aged 6 months and older, annually.
Where can I get vaccinated?	Community health centres
Learn More:	National Guidance Canadian Immunization Guide – Influenza Vaccine Northwest Territories Government of NWT – Immunization Schedule

National Recommendation (National Advisory Committee on Immunization)	Shingles vaccine is strongly recommended for all adults aged 18 years and older who are immunocompromised. It is also recommended for adults aged 50 years and older. The vaccine is given as a two-dose series, with the second dose typically administered 2 to 6 months after the first. For people who are immunocompromised, the interval may be shortened to as little as 4 weeks if needed.
Public Funding	⚠️ Adults aged 60 and older: Shingrix may be covered at no cost through an applicable public health-benefits program, including NWT Extended Health Benefits, Métis Health Benefits or NIHB. ⚠️ Eligible First Nations and Inuit: NIHB covers Shingrix at age 60 and older without prior approval. Immunocompromised clients under 60 may also be covered with prior approval. ⚠️ Adults aged 50–59: The vaccine is recommended but is not routinely funded based on age alone. Check private insurance or eligibility through a public benefits program.
Where can I get vaccinated?	Participating pharmacies Family doctor
Learn More:	National Guidance Canadian Immunization Guide – Shingles Northwest Territories Extended Health Care Benefits Government of NWT – Immunization Schedule (Health Care Professionals)

National Recommendation (National Advisory Committee on Immunization)	RSV vaccination is recommended for adults aged 75 years and older. Adults aged 60 to 74 years who are at increased risk of severe RSV disease may also benefit from vaccination. Adults aged 75 years and older who have received a hematopoietic stem cell transplant should receive RSV vaccination.
Public Funding	❌ Not publicly funded through a formal program (listed as “N/A” in the federal PHAC summary table). NWT’s public schedule notes it “may be considered for adults over 60” at provider discretion only. Cost if not funded is approximately $200–300 per dose out-of-pocket.
Where can I get vaccinated?	Community health centres (provider discretion, for adults over 60)
Learn More:	National Guidance Canadian Immunization Guide – RSV Vaccine Northwest Territories Government of NWT – Immunization Schedule

National Recommendation (National Advisory Committee on Immunization)	Pneu-C-20 or Pneu-C-21 is recommended for adults aged 65 years and older. Pneu-C-20 or Pneu-C-21 is also recommended for adults of any age who are immunocompromised or receiving immunosuppressive therapy. Most adults require one dose. If you have previously received an older pneumococcal vaccine (such as Pneu-P-23), you may still be eligible for Pneu-C-20. Speak with your healthcare provider about the schedule that is right for you.
Public Funding	✅ Publicly funded for adults 65 and older and ✅ for high-risk immunocompromised adults under 65 who are at risk of invasive pneumococcal disease. Autoimmune arthritis patients should qualify under the high-risk criteria.
Where can I get vaccinated?	Community health centres
Learn More:	National Guidance Canadian Immunization Guide – Pneumococcal Vaccine Northwest Territories NWT Pneu-C-20 information sheet Government of NWT – Immunization Schedule

National Recommendation (National Advisory Committee on Immunization)	HPV vaccination is recommended for everyone aged 9–26. Adults aged 27 and older may receive HPV vaccination following discussion and shared decision-making with a healthcare provider. If HPV vaccination is recommended for someone who is immunocompromised or living with HIV, a three-dose schedule is recommended, regardless of age. The usual schedule is: Dose 1: Day 0 Dose 2: 2 months after the first dose Dose 3: 6 months after the first dose
Public Funding	✅ Publicly funded for adults under 27 ✅ Publicly funded for adults 27 and over with ongoing risk of exposure. ❌ Not publicly funded for autoimmune arthritis, biologic, or DMARD (disease modifying anti-rheumatic drug) patients.
Where can I get vaccinated?	Community health centres
Learn More:	National Guidance Canadian Immunization Guide – HPV Vaccine Northwest Territories Government of NWT – Immunization Schedule

Nunavut

National Recommendation (National Advisory Committee on Immunization)	Most people for whom COVID-19 vaccination is recommended receive one dose per year. People who are moderately to severely immunocompromised are recommended to receive two COVID-19 vaccine doses each year, generally one in the fall and another in the spring. For people starting or restarting a COVID-19 vaccine series, a third dose may be offered in some circumstances.
Public Funding	✅ Publicly funded for all Nunavut residents aged 6 months and older.
Where can I get vaccinated?	Community health centres and public health offices across Nunavut
Learn More	National Guidance Canadian Immunization Guide – COVID-19 Vaccine Nunavut Government of Nunavut – Immunization

National Recommendation (National Advisory Committee on Immunization)	Influenza vaccination is recommended every year for everyone aged 6 months and older. People who are immunocompromised are a priority group and should receive a non-live influenza vaccine every year. The live attenuated influenza vaccine (FluMist®) is not recommended for people who are immunocompromised. High-dose flu vaccine or adjuvanted flu vaccines are recommended over standard-dose vaccines for adults aged 65 years and older.
Public Funding	✅ Publicly funded for all Nunavut residents aged 6 months and older, annually.
Where can I get vaccinated?	Community health centres
Learn More:	National Guidance Canadian Immunization Guide – Influenza Vaccine Nunavut Government of Nunavut – Immunization

National Recommendation (National Advisory Committee on Immunization)	Shingles vaccine is strongly recommended for all adults aged 18 years and older who are immunocompromised. It is also recommended for adults aged 50 years and older. The vaccine is given as a two-dose series, with the second dose typically administered 2 to 6 months after the first. For people who are immunocompromised, the interval may be shortened to as little as 4 weeks if needed.
Public Funding	❌ Not publicly funded in Nunavut. There is no shingles program, and shingles is not listed in Nunavut’s Active Immunization Protocols. ⚠️ Eligible Inuit and registered First Nations clients may receive coverage through the federal Non-Insured Health Benefits program. ✅ Under NIHB, Shingles vaccine is covered without prior approval for eligible clients aged 60 and older. ⚠️It may be covered for clients receiving eligible cancer treatment or, with prior approval, for immunocompromised clients under 60 in the NIHB program. Cost is approximately $200–400 per dose, but private pharmacy access is essentially unavailable in most Nunavut communities.
Where can I get vaccinated?	Not available in most Nunavut communities Limited private pharmacy access in Iqaluit only
Learn More:	National Guidance Canadian Immunization Guide – Shingles Nunavut Government of Nunavut – Active Immunization Protocols Non-Insured Health Benefits

National Recommendation (National Advisory Committee on Immunization)	RSV vaccination is recommended for adults aged 75 years and older. Adults aged 60 to 74 years who are at increased risk of severe RSV disease may also benefit from vaccination. Adults aged 75 years and older who have received a hematopoietic stem cell transplant should receive RSV vaccination.
Public Funding	✅ Publicly funded for Nunavummiut age 65 years and older. ❌ Adults under 65, including immunocompromised adults, are not publicly funded
Where can I get vaccinated?	Community health centres
Learn More:	National Guidance Canadian Immunization Guide – RSV Vaccine Nunavut Government of Nunavut – Active Immunization Protocols

National Recommendation (National Advisory Committee on Immunization)	Pneu-C-20 or Pneu-C-21 is recommended for adults aged 65 years and older. Pneu-C-20 or Pneu-C-21 is also recommended for adults of any age who are immunocompromised or receiving immunosuppressive therapy. Most adults require one dose. If you have previously received an older pneumococcal vaccine (such as Pneu-P-23), you may still be eligible for Pneu-C-20. Speak with your healthcare provider about the schedule that is right for you.
Public Funding	✅ Publicly funded for adults 50 and older ✅ Publicly funded for high-risk adults at any age with an immunocompromising condition. Eligibility is based on “Immunocompromising conditions or immunosuppressive therapy, within the last 2 years, including use of long-term corticosteroids, chemotherapy, radiation therapy, and immunosuppressive biologics.”
Where can I get vaccinated?	Community health centres
Learn More:	National Guidance Canadian Immunization Guide – Pneumococcal Vaccine Nunavut Government of Nunavut – Active Immunization Protocols

National Recommendation (National Advisory Committee on Immunization)	HPV vaccination is recommended for everyone aged 9–26. Adults aged 27 and older may receive HPV vaccination following discussion and shared decision-making with a healthcare provider. If HPV vaccination is recommended for someone who is immunocompromised or living with HIV, a three-dose schedule is recommended, regardless of age. The usual schedule is: Dose 1: Day 0 Dose 2: 2 months after the first dose Dose 3: 6 months after the first dose
Public Funding	✅ Publicly funded for adults under 27 (historically Grade 6) ✅ Publicly funded for high-risk individuals 28 and older, with no stated upper age limit or description of ‘high-risk’. ❌ Not publicly funded for autoimmune arthritis, biologic, or DMARD (disease modifying anti-rheumatic drug) patients.
Where can I get vaccinated?	Community health centres
Learn More:	National Guidance Canadian Immunization Guide – HPV Vaccine Nunavut Government of Nunavut – Active Immunization Protocols